or Try an Advanced Search...

    Solid Tumor Cancers Stocks List

    Symbol Grade Name % Change
    NEO C NeoGenomics, Inc. -1.47
    NVCR C NovoCure Limited 13.01
    MNOV D MediciNova, Inc. -2.63
    CRDF D Cardiff Oncology, Inc. 2.87
    CKPT F Checkpoint Therapeutics, Inc. 1.30
    IMCR F Immunocore Holdings plc -2.00
    INAB F IN8bio, Inc. 1.96
    NCNA F NuCana plc 4.02
    GNTA F Genenta Science S.p.A. -8.15
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Cancer Medicine Clinical Medicine Oncology Biotechnology Solid Tumors Biology Brain Tumor Cancer Immunotherapy Chemotherapy Glioblastoma Leukemia Lymphoma Small Cell Lung Cancer Treatment Of Cancer Acute Leukemia Acute Myeloid Leukemia Adenosine Advanced Solid Tumors Aging Associated Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumor Cancers stocks.

    Symbol Grade Name Weight
    GERM C ETFMG Treatments Testing and Advancements ETF 3.63
    XHS C SPDR S&P Health Care Services ETF 1.99
    SBIO D ALPS Medical Breakthroughs ETF 1.9
    BBP C BioShares Biotechnology Products Fund 1.84
    PSCH B PowerShares S&P SmallCap Health Care Portfolio 1.65
    View all Solid Tumor Cancers ETFs...
    Compare ETFs
    Compare GERM to XHS Compare SBIO to BBP Compare SBIO to PSCH

        Solid Tumor Cancers Stocks Recent News

        Date Stock Title
        May 14 INAB IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
        May 14 MNOV MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome
        May 13 CRDF Cardiff Oncology to Present at Upcoming Investor Conferences in May
        May 13 CKPT Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
        May 13 INAB IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024
        May 12 CKPT Checkpoint Therapeutics First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.89 loss in 1Q 2023)
        May 11 IMCR Analysts Have Made A Financial Statement On Immunocore Holdings plc's (NASDAQ:IMCR) First-Quarter Report
        May 10 CKPT Checkpoint Therapeutics GAAP EPS of -$0.33
        May 10 CKPT Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
        May 10 INAB IN8bio GAAP EPS of -$0.20 misses by $0.03
        May 10 NEO NeoGenomics Earnings Analysis: Q1 Recap
        May 9 INAB IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
        May 8 IMCR Immunocore GAAP EPS of -$0.49 misses by $0.13, revenue of $70.5M beats by $1.32M
        May 8 IMCR Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts
        May 8 IMCR Immunocore reports first quarter financial results and provides a business update
        Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
        Related Stock Lists: Cancer Medicine Clinical Medicine Oncology Biotechnology Solid Tumors Biology Brain Tumor Cancer Immunotherapy Chemotherapy Glioblastoma Leukemia Lymphoma Small Cell Lung Cancer Treatment Of Cancer Acute Leukemia Acute Myeloid Leukemia Adenosine Advanced Solid Tumors Aging Associated Diseases
        Solid Tumor Cancers

        Solid tumor cancers are a type of cancer that forms in solid organs or tissues of the body. These tumors can be benign (non-cancerous) or malignant (cancerous). Solid tumor cancers can occur in any organ or tissue, including the brain, breast, colon, pancreas, and prostate. Treatment for solid tumor cancers typically involves surgery, chemotherapy, radiation, and/or targeted therapy.

        Browse All Tags